Final five-year clinical outcomes in the EVOLVE trial: A randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent.

Abstract

AIMS Long-term data for bioabsorbable polymer-coated everolimus-eluting stents (BP-EES) are limited. The EVOLVE trial compared the safety and efficacy of 2 dose formulations of SYNERGY BP-EES with permanent polymer-coated PROMUS Element EES (PE). METHODS AND RESULTS The EVOLVE study was a prospective, multicentre, noninferiority trial that randomised 291… (More)
DOI: 10.4244/EIJ-D-17-00529

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.